Patents by Inventor Peter Swetly

Peter Swetly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use
    Patent number: 5837842
    Abstract: This invention relates to biologically active proteins, the DNA molecules coding for them, processes for preparing them and their use.
    Type: Grant
    Filed: January 23, 1995
    Date of Patent: November 17, 1998
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rudolf Hauptmann, Ingrid Maurer-Fogy, Gerhard Bodo, Peter Swetly, Christian Stratowa, Edgar Falkner, Gunther Adolf, Christiaan Maria Peter Reutelingsperger
  • Recombinant production of dog and horse type I interferons
    Patent number: 5798228
    Abstract: This invention relates to a process for preparing recombinant horse and dog interferons and the interferons themselves.
    Type: Grant
    Filed: February 24, 1997
    Date of Patent: August 25, 1998
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Adolf Himmler, Rudolf Hauptmann, Norbert Hauel, Gunther Adolf, Peter Swetly
  • Human lysozyme
    Patent number: 5618712
    Abstract: This invention relates to a process for preparing human lysozyme and the human lysozyme protein itself.
    Type: Grant
    Filed: April 4, 1994
    Date of Patent: April 8, 1997
    Assignee: Boehringer Ingelheim Zentrale GmbH
    Inventors: Andrzej Sledziewski, Ewa Chlebowicz-Sledziewska, Peter Swetly, Gunther Adolf, Rudolf Hauptmann, Maria J. Castanon, Walter Spevak
  • Recombinant dog and horse type I interferons
    Patent number: 5605688
    Abstract: This invention relates to a process for preparing recombinant horse and dog interferons and the interferons themselves.
    Type: Grant
    Filed: September 8, 1994
    Date of Patent: February 25, 1997
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Adolf Himmler, Rudolf Hauptmann, Norbert Hauel, Gunther Adolf, Peter Swetly
  • DNA encoding equine-gamma interferon and recombinant production of equine IFN-.gamma. polypeptides
    Patent number: 5602010
    Abstract: The present invention relates to a process for preparing horse interferon-gamma (equine interferon gamma, EqIFN-.gamma., DNA sequences which encode this polypeptide, suitable vectors and host organisms containing these DNA sequences and the EqIFN-.gamma. itself. The invention further relates to partial DNA sequences which encode polypeptides which differ structurally from the natural EqIFN-.gamma. polypeptide. The use of the proteins is also described.
    Type: Grant
    Filed: June 17, 1994
    Date of Patent: February 11, 1997
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rudolf Hauptmann, Adolf Himmler, Peter Swetly
  • Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them
    Patent number: 4917887
    Abstract: This invention relates to new hybrid interferons consisting of part of an .alpha.-interferon and part of an omega interferon, the N-terminal Met or N-formyl-Met derivatives thereof and, if the peptide sequence of the hybrid interferon contains a glycosylation site, the N-glycosylated derivatives thereof, their use as pharmaceutical compositions and as intermediate products for immunizing experimental animals and processes for producing them,new monoclonal antibodies and their use in purifying .alpha. and omega-interferons, the hybrid cell lines which secrete them and processes for preparing them,a new process for purifying .alpha. and omega-interferons by means of a new antibody affinity column containing the above-mentioned new monoclonal antibodies, and processes for the preparation thereof,new hybrid plasmids for improving the expression of omega-interferons and new intermediate plasmids for preparing the new plasmids and processes for the preparation thereof.
    Type: Grant
    Filed: March 9, 1987
    Date of Patent: April 17, 1990
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rudolf Hauptmann, Peter Swetly, Peter Meindl, Gunther Adolf, Edgar Falkner, Gerhard Bodo, Ingrid Maurer-Fogy
  • Novel alpha interferon species produced by recombinant means
    Patent number: 4820638
    Abstract: A novel species of alpha interferon is taught. The alpha interferon amino acid sequence is disclosed and a gene corresponding thereto. The alpha interferon gene is expressed in Escherichia coli.
    Type: Grant
    Filed: May 19, 1983
    Date of Patent: April 11, 1989
    Assignee: Dr. Karl Thomae GmbH
    Inventors: Peter Swetly, Eva Dworkin-Rastl, Peter Meindl
  • Tridecadeoxynucleotide, process for preparation thereof, and use thereof
    Patent number: 4433140
    Abstract: A tridecadeoxynucleotide of the formuladCCTTCTGGAACTG,is useful as a primer in the enzymatic synthesis of deoxyribonucleic acid (DNA) on messenger ribonucleic acid (mRNA) matrices.The new tridecadeoxynucleotide is obtained by linking suitable partially protected oligonucleotide blocks, particularly two suitable oligonucleotide fragments, e.g. by linking a suitable tetramer to a suitable nomaer, using a condensing agent.
    Type: Grant
    Filed: February 24, 1982
    Date of Patent: February 21, 1984
    Assignee: Dr. Karl Thomae GmbH
    Inventors: Hartmut Seliger, Eva Rastl, Peter Swetly
  • Tridecapeptide
    Patent number: 4376760
    Abstract: The tridecapeptide of the formulaH-Met-Ser-Tyr-Asn-Leu-Leu-Gly-Phe-Leu-Gln-Arg-Ser-Ser-OHand the use thereof as a hapten, tracer or antibody.
    Type: Grant
    Filed: October 26, 1981
    Date of Patent: March 15, 1983
    Assignee: Dr. Karl Thomae Gesellschaft mit beschrankter Haftung
    Inventors: Gunther Jung, Hans Bruckner, Peter Swetly, Gerhard Bozler
  • Decapeptide
    Patent number: 4370312
    Abstract: The decapeptide of the formulaH-Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-OHand the use thereof as hapten, tracer or antibody.
    Type: Grant
    Filed: October 26, 1981
    Date of Patent: January 25, 1983
    Assignee: Dr. Karl Thomae Gesellshaft mit beschrankter Haftung
    Inventors: Gunther Jung, Hans Bruckner, Peter Swetly, Gerhard Bozler
  • Process for the production of human interferon
    Patent number: 4266024
    Abstract: This invention is directed to a process of producing interferon which comprises incubating permanent cell lines of lymphoblast origin or human fibroblast cells with interferon inducers and stimulator substances and recovering the interferon produced.
    Type: Grant
    Filed: May 14, 1979
    Date of Patent: May 5, 1981
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Peter Swetly, Gunther R. Adolf, Gerhard Bodo, Silvia J. Lindner-Frimmel, Peter Meindl, Hans Tuppy
  • Antiviral compositions
    Patent number: 4046879
    Abstract: A topical pharmaceutical antiviral composition consisting essentially of an inert pharmaceutical carrier or diluent, a complex-former for bivalent cations, and a 5'-triphosphate of a nucleoside or deoxyribonucleoside.
    Type: Grant
    Filed: March 1, 1976
    Date of Patent: September 6, 1977
    Assignee: Boehringer Ingelheim GmbH
    Inventor: Peter Swetly